We are passionate about advances in oncology and we’ve created a novel approach to support oncology discoveries. We’re the first comprehensive, fully integrated solution exclusively devoted to oncology innovation. For an overview, keep reading and for a more an in-depth look, click the logo below.
Accelerated pathway to proof of concept. Our novel approach of integrating clinical development, specialty assays, and biomarker data management and analytics enhances the predictability of achieving study goals and obtaining objective data to inform future development decisions.
Early phase Oncology Site Network for predictable start-up and performance. Our turnkey network of qualified oncology sites aligns capabilities to sponsors’ goals, grounded in a commitment to a 90-day study start-up—and a track record of success.
Highly experienced, oncology-only clinical trial team. We have an average of 12+ years of monitoring experience and a vast knowledge of oncology research.
Advanced custom assays for all stages and applications. Our team can create and manage all specialty assays that are critical requirements for a comprehensive biomarker and patient stratification strategy. We can design a custom and phase-appropriate lab solution that is fully integrated with trial execution at a global scale.
Biomarker Data Management. Rapidly harmonize, synthesize, and visualize specialty lab data from multiple vendors and diverse assays.
Translational Informatics and innovative data delivery. Our solutions for specialty biomarker data run the full range from standard statistical analysis to advanced analytics for data translational research. Stratify patients, identify a novel drug target, or understand an MoA.